We explored the theorized upregulation of platelet-activating factor ( PAF ) - mediated biologic responses following lipoprotein-associated phospholipase A2 ( Lp-PLA2 ) inhibition using human platelet aggregation studies in an in vitro experiment and in 2 clinical trials .